Metastatic CRC: Better tumor response and disease control with FTD/TPI vs regorafenib September 18, 2021GI Oncology
Oncology PracticeColorectal polyps often recur after incomplete resectionAugust 9, 2021GastroenterologyGI OncologyGastrointestinal Cancer
Oncology PracticeShorter HCC screening intervals benefit high-risk patientsAugust 4, 2021GastroenterologyGI Oncology
Oncology PracticeAGA Clinical Practice Update Expert Review: Management of malignant alimentary tract obstructionAugust 3, 2021GastroenterologyGI Oncology
Avoiding intensive chemotherapy due to older age alone is not advisable in mCRCJune 24, 2021GI Oncology
Diagnostic efficacy of fecal immunochemical tests for assessment of suspected symptomatic CRC in primary careJune 24, 2021GI Oncology
FTD/TPI effective and well tolerated in elderly patients with advanced colorectal cancerJune 24, 2021GI Oncology
Dietary vitamin D intake tied to lower risk for colorectal cancer in patients at high CV riskJune 24, 2021GI Oncology
Obesity tied to increased risk for colorectal cancer in patients with Lynch syndromeJune 24, 2021GI Oncology
Cumulative social risk linked to reduced receipt of chemotherapy in patients with advanced CRCJune 24, 2021GI Oncology
HLX04, an alternative biosimilar to bevacizumab for refractory/metastatic colorectal cancerJune 24, 2021GI Oncology
Perioperative systemic therapy feasible and safe in patients with resectable colorectal peritoneal metastasesJune 24, 2021GI Oncology
